Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the optimal dose and administration methods of
CJ-12420 in patients with erosive esophagitis by comparing the safety and efficacy of orally
administered CJ-12420 to esomeprazole 40mg.